Andrzej Dlugosz was named associate director for basic science research at the University of Michigan Rogel Cancer Center.
Leonard Freedman was named chief science officer at the Frederick National Laboratory for Cancer Research.
Johnathan Whetstine was named program leader of the Cancer Epigenetics Program at Fox Chase Cancer Center.
The National Comprehensive Cancer Network and Syapse announced an agreement w to expand the use of best practices in precision medicine.
Advance care planning is a process for patients and their families to discuss their wishes and goals of care for treatment and end-of-life care, clarify related values and goals, and state preferences through written documents and medical orders.
Stand Up To Cancer announced the launch of an in-store fundraising campaign at CVS Pharmacy locations across the country, as part of its collaboration with CVS Health.
Paul Goldberg spoke with Samuel Waksal.
Brian SlomovitzDirector, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Miami, Miller School of Medicine Co-leader, Gynecologic Cancers Site Disease Group, Sylvester Comprehensive Cancer CenterThe primary objective of these studies is survival or recurrence rates—we can’t overlook those objectives and those findings, even if robotic surgery can give you a shorter length of stay.
Women who were subjected to minimally invasive surgery for early-stage cervical cancer were four times more likely to die from that disease within three years, three times more likely to have a recurrence within three years, and had shorter overall survival, compared to women who underwent open surgery, according to two groundbreaking studies published in The New England Journal of Medicine Oct. 31.
When cervical cancer patients were referred to MD Anderson Cancer Center for a prospective, phase III trial testing for noninferiority of minimally invasive vs. open abdominal radical hysterectomy, many requested the minimally invasive approach, because their referring physicians said it was better, said Pedro Ramirez, a professor of gynecologic oncology at MD Anderson.
